O'GRADY BRENDAN P. (EVP, North America Commercial) sold 70.9% of their position (73.13K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $798.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/2/2021ACC: 0001209191-21-015852
Officer· EVP, North America Commercial
Since Sep 2018
-73.13K
Net shares
Net seller
$798.0K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
24.93K acquired · 98.06K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
+24.93K
Price / share
—
Trade value
—
% of position
31.9%
2/28/2021
78.15K→103.08K
Ordinary Shares
Direct
Shares
−9.85K
Price / share
$10.83
Trade value
$106.67K
% of position
9.6%
3/1/2021
103.08K→93.23K
Ordinary Shares
Direct
Shares
−63.28K
Price / share
$10.93
Trade value
$691.35K
% of position
67.9%
3/1/2021
93.23K→29.95K
Total
Net shares
−48.19K
Net value
-$798.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/28/2021 | M · Option Exercise | +24.93K | — | — | 31.9% | 78.15K | 103.08K |
| Ordinary Shares Direct | 3/1/2021 | S · Sale | −9.85K | $10.83 | $106.67K | 9.6% | 103.08K | 93.23K |
| Ordinary Shares Direct | 3/1/2021 | S · Sale | −63.28K | $10.93 | $691.35K | 67.9% | 93.23K | 29.95K |
| Total | −48.19K | -$798.02K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
24.93K shares
Shares
−24.93K
Strike price
Held after
74.81K
Exercisable
—
2/28/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares24.93K shares | 2/28/2021 | M · Option Exercise | −24.93K | — | 74.81K |